Marked improvement of platelet transfusion refractoriness after bortezomib therapy in multiple myeloma.
Miki H, Ozaki S, Tanaka O, Lee E, Takimoto T, Watanabe H, Fujii S, Nakamura S, Kagawa K, Takeuchi K, Yata KI, Abe M, Kagami S, Matsumoto T.
Miki H, et al. Among authors: kagami s.
Int J Hematol. 2009 Mar;89(2):223-226. doi: 10.1007/s12185-009-0255-z. Epub 2009 Feb 20.
Int J Hematol. 2009.
PMID: 19225725